Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001638599-21-000014

Options or other derivatives

  • Chief Executive Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Mahesh V. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +275,000 $1.43 $393,250 275,000 D
Loading xslF345X03/doc4_6979.xml…